| Literature DB >> 29866053 |
Brittney N Keel1, Christina M Zarek1,2, John W Keele1, Larry A Kuehn1, Warren M Snelling1, William T Oliver1, Harvey C Freetly1, Amanda K Lindholm-Perry3.
Abstract
BACKGROUND: Feed intake and body weight gain are economically important inputs and outputs of beef production systems. The purpose of this study was to discover differentially expressed genes that will be robust for feed intake and gain across a large segment of the cattle industry. Transcriptomic studies often suffer from issues with reproducibility and cross-validation. One way to improve reproducibility is by integrating multiple datasets via meta-analysis. RNA sequencing (RNA-Seq) was performed on longissimus dorsi muscle from 80 steers (5 cohorts, each with 16 animals) selected from the outside fringe of a bivariate gain and feed intake distribution to understand the genes and pathways involved in feed efficiency. In each cohort, 16 steers were selected from one of four gain and feed intake phenotypes (n = 4 per phenotype) in a 2 × 2 factorial arrangement with gain and feed intake as main effect variables. Each cohort was analyzed as a single experiment using a generalized linear model and results from the 5 cohort analyses were combined in a meta-analysis to identify differentially expressed genes (DEG) across the cohorts.Entities:
Keywords: Beef cattle; Differential expression; Feed efficiency; Meta-analysis; RNA-Seq; Transcriptome
Mesh:
Year: 2018 PMID: 29866053 PMCID: PMC5987596 DOI: 10.1186/s12864-018-4769-8
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Length of time and diets used for feed trials
| Year Born | Time of Slaughter | Start Date | End Date | Days on Study | Dieta |
|---|---|---|---|---|---|
| 2011 | Spring 2012 | 04/11/12 | 06/14/12 | 64 | ME02 |
| 2011 | Fall 2012 | 07/10/12 | 10/10/12 | 92 | ME01 |
| 2012 | Spring 2013 | 04/16/13 | 06/19/13 | 64 | ME01 |
| 2012 | Fall 2013 | 07/24/13 | 10/16/13 | 84 | TM01 |
| 2013 | Fall 2014 | 07/29/14 | 10/15/14 | 78 | TM01 |
aDiet composition provided in Table 2
Composition of diets used in feed trials
| ME01 | ME02 | TM01 | |
|---|---|---|---|
| Dry rolled corn | 57.35% | 0% | 57.35% |
| Ground alfalfa hay | 8% | 8% | 8% |
| High moisture corn | 0% | 57.75% | 0% |
| Steakmaker®a | 4.25% | 4.25% | 0% |
| Steakmaker with Tylanb | 0% | 0% | 4.25% |
| Urea | 0.4% | 0% | 0.4% |
| Wet distiller’s grains with solubles | 30% | 30% | 30% |
aManufactured by Land O’Lakes (Arden Hills, MN)
bTylan manufactured by Elanco Animal Health (Greenfield, IN)
Fig. 1Total gain versus total dry matter intake over the trial period was plotted for all animals (n = 80) used in this study. Cohorts are represented by the color of the dots
Summary statistics for ADG and ADFI (Kg/day) in the animals selected from each of the cohorts
| Mean ADG | Min. ADG | Max. ADG | Mean ADFI | Min. ADFI | Max. ADFI | |
|---|---|---|---|---|---|---|
| Spring 2012 | ||||||
| High Gain-High Intake | 2.22 | 1.98 | 2.49 | 26.83 | 22.08 | 31.10 |
| Low Gain-High Intake | 1.55 | 1.42 | 1.64 | 23.48 | 21.83 | 25.61 |
| Low Gain-Low Intake | 1.21 | 1.05 | 1.52 | 14.54 | 12.25 | 18.97 |
| High Gain-Low Intake | 1.85 | 1.75 | 2.05 | 15.29 | 13.91 | 16.65 |
| Fall 2012 | ||||||
| High Gain-High Intake | 2.26 | 2.09 | 2.36 | 8.49 | 8.00 | 8.91 |
| Low Gain-High Intake | 1.68 | 1.53 | 1.90 | 8.24 | 7.8 | 8.55 |
| Low Gain-Low Intake | 1.54 | 1.43 | 1.70 | 5.81 | 5.30 | 6.20 |
| High Gain-Low Intake | 2.02 | 1.35 | 2.31 | 7.31 | 6.19 | 9.70 |
| Spring 2013 | ||||||
| High Gain-High Intake | 2.06 | 1.90 | 2.26 | 13.82 | 12.40 | 14.65 |
| Low Gain-High Intake | 1.28 | 1.14 | 1.51 | 12.22 | 11.41 | 13.40 |
| Low Gain-Low Intake | 0.90 | 0.86 | 0.99 | 8.48 | 7.39 | 9.22 |
| High Gain-Low Intake | 1.70 | 1.56 | 1.79 | 9.35 | 8.60 | 10.04 |
| Fall 2013 | ||||||
| High Gain-High Intake | 2.23 | 1.93 | 2.43 | 14.40 | 12.09 | 16.53 |
| Low Gain-High Intake | 1.48 | 1.02 | 1.84 | 13.51 | 12.06 | 14.93 |
| Low Gain-Low Intake | 1.61 | 1.33 | 1.88 | 8.84 | 8.52 | 9.43 |
| High Gain-Low Intake | 1.98 | 1.90 | 2.07 | 9.08 | 7.51 | 9.98 |
| Fall 2014 | ||||||
| High Gain-High Intake | 2.43 | 2.20 | 2.63 | 12.27 | 10.92 | 13.67 |
| Low Gain-High Intake | 1.65 | 1.51 | 1.76 | 10.52 | 10.10 | 10.79 |
| Low Gain-Low Intake | 1.47 | 1.10 | 1.73 | 7.12 | 6.74 | 7.37 |
| High Gain-Low Intake | 2.24 | 2.19 | 2.31 | 9.13 | 9.06 | 9.19 |
Significant pathways for DEGs associated with the gain main effect identified using IPA
| Pathway | DEGs in Pathway | |
|---|---|---|
| Mitochondrial Dysfunction | 0.00296 |
|
| Glycerol-3-phosphate shuttle | 0.00672 |
|
| Glycerol degradation I | 0.0101 |
|
| Death receptor signaling | 0.0107 |
|
| VEGF signaling | 0.013 |
|
| Oxidative phosphorylation | 0.0145 |
|
| Phosphatidylethanolamine biosynthesis II | 0.0151 |
|
| Pancreatic adenocarcinoma signaling | 0.0169 |
|
| Gai signaling | 0.0174 |
|
| nNOS signaling in skeletal muscle cells | 0.025 |
|
| Glutathione redox reactions I | 0.0397 |
|
| NRF2-mediated oxidative stress response | 0.0418 |
|
| ILK signaling | 0.043 |
|
aCorrected for multiple testing using Benjamini Hochberg method
Significant pathways for DEGs associated with the intake main effect identified using IPA
| Pathway | DEGs in Pathway | |
|---|---|---|
| 4-hydroxyproline degradation I | 0.00803 |
|
| Methylglyoxal degradation I | 0.012 |
|
| D-glucuronate degradation I | 0.012 |
|
| Glycerol-3-phosphate shuttle | 0.016 |
|
| Arginine degradation I (arginase pathway) | 0.016 |
|
| Arginine biosynthesis IV | 0.0239 |
|
| Proline biosynthesis II (from arginine) | 0.0239 |
|
| Arginine degradation VI (arginase 2 pathway) | 0.0239 |
|
| Glycerol degradation I | 0.0239 |
|
| CNTF signaling | 0.0267 |
|
| Citrulline biosynthesis | 0.0318 |
|
| PPARa/RXRa activation | 0.0362 |
|
aCorrected for multiple testing using Benjamini Hochberg method
Significant pathways for DEGs associated with the gain by intake interaction effect identified using IPA
| Pathway | DEGs in Pathway | |
|---|---|---|
| GADD45 signaling | 0.00886 |
|
| Pyridoxal 5′-phosphate salvage pathway | 0.03 |
|
| Caveolar-mediated endocytosis signaling | 0.0327 |
|
| ATM signaling | 0.0368 |
|
aCorrected for multiple testing using Benjamini Hochberg method